SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+1.71%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$328M
AUM Growth
+$328M
(+5.9%)
Cap. Flow
+$35M
Cap. Flow
% of AUM
10.65%
Top 10 Holdings %
Top 10 Hldgs %
52.5%
Holding
83
New
20
Increased
13
Reduced
10
Closed
12
Top Buys
| 1 |
MSAC
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
|
$22.6M |
| 2 |
Cencora
COR
|
$12.9M |
| 3 |
Cardinal Health
CAH
|
$9.98M |
| 4 |
Ionis Pharmaceuticals
IONS
|
$9.82M |
| 5 |
Merck
MRK
|
$8.33M |
Top Sells
| 1 |
SOLY
Soliton, Inc.
SOLY
|
$16.8M |
| 2 |
HCA Healthcare
HCA
|
$13.7M |
| 3 |
Universal Health Services
UHS
|
$12.9M |
| 4 |
HealthEquity
HQY
|
$4.76M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$4.63M |
Sector Composition
| 1 | Healthcare | 84.57% |
| 2 | Financials | 6.88% |
| 3 | Consumer Staples | 3.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Protagonist Therapeutics
PTGX
$3.62B
| – | – |
-90,000
| Closed | -$1.6M |
|
77
Quince Therapeutics
QNCX
$86.5M
| – | – |
0
| – | – |
|
|
78
Vertex Pharmaceuticals
VRTX
$102B
| – | – |
-25,500
| Closed | -$4.63M |
|
|
SPRB
79
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| – | – |
-603,027
| Closed | -$3.62M |
|
|
BLU
80
DELISTED
BELLUS Health Inc.
BLU
| – | – |
0
| – | – |
|
|
RUBY
81
DELISTED
Rubius Therapeutics, Inc
RUBY
| – | – |
-6,200
| Closed | -$111K |
|
|
RDUS
82
DELISTED
Radius Health, Inc.
RDUS
| – | – |
-241,905
| Closed | -$3M |
|
|
SOLY
83
DELISTED
Soliton, Inc.
SOLY
| – | – |
-824,803
| Closed | -$16.8M |
|